Search Result

No matches for "

57684

" within the MedChemExpress (MCE) catalog. Here are the results you might be looking for.

By Targets:	5-HT Receptor (1) Cytochrome P450 (1) MicroRNA (12)
By Research Areas:	Cancer (13) Neurological Disease (1)
Oligonucleotides:	miRNA mimics (3) miRNA antagomirs (3) miRNA agomirs (3) MicroRNAs (12) miRNA inhibitors (3)

Inhibitors & Agonists

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-156628

Opevesostat MK-5684; ODM-208	Cytochrome P450	Cancer
Opevesostat (MK-5684; ODM-208) is an orally active and selective CYP11A1 inhibitor. Opevesostat has the potential for the research of metastatic castration-resistant prostate cancer (mCRPC) .

HY-103120

Org37684	5-HT Receptor	Neurological Disease
Org37684 is a highly potent 5-HT_2C receptor agonist (pEC₅₀=8.17). Org37684 exhibits a rank order of potency of 5-HT_2C>5-HT_2B>5-HT_2A. Its selectivity for the 5-HT2C receptor is approximately 2.5 times over the 5-HT2B (pEC₅₀=7.96) and ten times for the 5-HT_2A (pEC₅₀=7.11) receptor .

HY-R01763

*hsa-miR-5684* mimic**	MicroRNA	Cancer
hsa-miR-5684 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-5684 mimic hsa-miR-5684 mimic

HY-R04118

*mmu-miR-7684-3p mimic*	MicroRNA	Cancer
mmu-miR-7684-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-7684-3p mimic mmu-miR-7684-3p mimic

HY-RI04118

*mmu-miR-7684-3p inhibitor*	MicroRNA	Cancer
mmu-miR-7684-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-7684-3p inhibitor mmu-miR-7684-3p inhibitor

HY-R04119

*mmu-miR-7684-5p mimic*	MicroRNA	Cancer
mmu-miR-7684-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-7684-5p mimic mmu-miR-7684-5p mimic

HY-R01763A

*hsa-miR-5684* agomir**	MicroRNA	Cancer
hsa-miR-5684 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-5684 agomir hsa-miR-5684 agomir

HY-RI01763

*hsa-miR-5684* inhibitor**	MicroRNA	Cancer
hsa-miR-5684 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-5684 inhibitor hsa-miR-5684 inhibitor

HY-RI01763A

*hsa-miR-5684* antagomir**	MicroRNA	Cancer
hsa-miR-5684 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-5684 antagomir hsa-miR-5684 antagomir

HY-R04118A

*mmu-miR-7684-3p agomir*	MicroRNA	Cancer
mmu-miR-7684-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-7684-3p agomir mmu-miR-7684-3p agomir

HY-RI04119A

*mmu-miR-7684-5p antagomir*	MicroRNA	Cancer
mmu-miR-7684-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-7684-5p antagomir mmu-miR-7684-5p antagomir

HY-RI04119

*mmu-miR-7684-5p inhibitor*	MicroRNA	Cancer
mmu-miR-7684-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-7684-5p inhibitor mmu-miR-7684-5p inhibitor

HY-RI04118A

*mmu-miR-7684-3p antagomir*	MicroRNA	Cancer
mmu-miR-7684-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-7684-3p antagomir mmu-miR-7684-3p antagomir

HY-R04119A

*mmu-miR-7684-5p agomir*	MicroRNA	Cancer
mmu-miR-7684-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-7684-5p agomir mmu-miR-7684-5p agomir

Host:	Mouse (4) Rabbit (5)
Reactivity:	Human (8) Rat (4) Mouse (4) Species independent (1)
Application:	IHC-P (5) ICC/IF (3) IF-Tissue (1) IP (4) IHC-F (1) WB (5) ELISA (7)
Isotype:	IgG (4) IgG1 (3) IgG/Kappa (1)
Conjugation:	Non-conjugated (9)
Clonality:	Monoclonal (7) Recombinant (2)
Modification:	Phosphorylated (1) Unmodified (7)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P85992

	Fascin Antibody (YA5684)	IHC-P, ELISA	Human, Mouse, Rat
	Fascin Antibody (YA5684) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Fascin.

HY-P87999

	Transmembrane Protein 85 Antibody (YA7684)	WB, IHC-P, IHC-F, IF-Tissue, IP	Human
	Transmembrane Protein 85 Antibody (YA7684) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Transmembrane Protein 85.

HY-P81063

	Sulfadimidine Antibody (YA906)(PBS only) sulfamethazine; Sulfadimidine; 57-68-1; Sulphamethazine; Sulfadimethyldiazine;	ELISA	Species independent
	Sulfadimidine Antibody (YA906) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Sulfadimidine.

HY-P85376

	SRA1 Antibody (YA5068) SRA1; PP7684; Steroid receptor RNA activator 1; Steroid receptor RNA activator protein; SRAP	IHC-P, ELISA	Human
	SRA1 Antibody (YA5068) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to SRA1.

HY-P85376A

	SRA1 Antibody (YA5068)(PBS only) SRA1; PP7684; Steroid receptor RNA activator 1; Steroid receptor RNA activator protein; SRAP	IHC-P, ELISA	Human
	SRA1 Antibody (YA5068) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to SRA1.

HY-P86072

	Cleaved Caspase-7 (Asp198) Antibody (YA5764) CASP7; MCH3; Caspase-7; CASP-7; Apoptotic protease Mch-3; CMH-1; ICE-like apoptotic protease 3; ICE-LAP3	WB, ICC/IF, IP, ELISA	Human, Mouse, Rat
	Cleaved Caspase-7 (Asp198) Antibody (YA5764) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Cleaved Caspase-7 (Asp198).

HY-P86092

	Nrf2 Antibody (YA5784) Nuclear factor erythroid 2-related factor 2; NF-E2-related factor 2; NFE2-related factor 2; HEBP1; Nuclear factor, erythroid derived 2, like 2;	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	Nrf2 Antibody (YA5784) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Nrf2.

HY-P86076

	Phospho-IGF1R(Tyr1135/1136)/Insulin Receptor β(Tyr1150/1151) Antibody (YA5768) IGF1R; Insulin-like growth factor 1 receptor; Insulin-like growth factor I receptor; IGF-I receptor; CD antigen CD221; INSR; Insulin receptor; IR; CD antigen CD220	WB, ICC/IF, IP, ELISA	Human, Mouse, Rat
	Phospho-IGF1R(Tyr1135/1136)/Insulin Receptor β(Tyr1150/1151) Antibody (YA5768) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-IGF1R(Tyr1135/1136)/Insulin Receptor β(Tyr1150/1151).

HY-P85540

	TAB1(N-term) Antibody (YA5232) 2310012M03Rik; 3'-Tab1; MAP3K7IP 1; MAP3K7IP1; MGC57664; Mitogen activated protein kinase kinase kinase 7 interacting protein 1; Mitogen-activated protein kinase kinase kinase 7-interacting protein 1; TAB 1; TAB1; TAB1_HUMAN; TAK1 binding protein 1; TAK1-binding protein 1; TGF beta activated kinase 1 binding protein 1; TGF-beta activated kinase 1/MAP3K7 binding protein 1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1; TGF-beta-activated kinase 1-binding protein 1; Transforming growth factor beta activated kinase binding protein 1.	WB	Human
	TAB1(N-term) Antibody (YA5232) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to TAB1(N-term).

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-R01763

*hsa-miR-5684* mimic**		MicroRNAs miRNA mimics
hsa-miR-5684 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R04118

*mmu-miR-7684-3p mimic*		MicroRNAs miRNA mimics
mmu-miR-7684-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-RI04118

*mmu-miR-7684-3p inhibitor*		MicroRNAs miRNA inhibitors
mmu-miR-7684-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-R04119

*mmu-miR-7684-5p mimic*		MicroRNAs miRNA mimics
mmu-miR-7684-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R01763A

*hsa-miR-5684* agomir**		MicroRNAs miRNA agomirs
hsa-miR-5684 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI01763

*hsa-miR-5684* inhibitor**		MicroRNAs miRNA inhibitors
hsa-miR-5684 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI01763A

*hsa-miR-5684* antagomir**		MicroRNAs miRNA antagomirs
hsa-miR-5684 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R04118A

*mmu-miR-7684-3p agomir*		MicroRNAs miRNA agomirs
mmu-miR-7684-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI04119A

*mmu-miR-7684-5p antagomir*		MicroRNAs miRNA antagomirs
mmu-miR-7684-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI04119

*mmu-miR-7684-5p inhibitor*		MicroRNAs miRNA inhibitors
mmu-miR-7684-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI04118A

*mmu-miR-7684-3p antagomir*		MicroRNAs miRNA antagomirs
mmu-miR-7684-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R04119A

*mmu-miR-7684-5p agomir*		MicroRNAs miRNA agomirs
mmu-miR-7684-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

Inquiry Online

Submit your filled information, we will contact you soon.

Salutation:		* Country or Region:
* Applicant Name:		* Organization Name:
* Department:
* Email Address:		* Product Name:
Cat. No.:		* Requested quantity:
* Phone Number:
MCE Japan Authorized Agent:	ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Remarks:

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: